Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc > Looks like insiders are dumping

<< Previous

Bullboard Posts

Next >>

Comment by Alba1314on Jul 16, 2018 11:48am

102 Views

Post# 28321269

RE:RE:Looks like insiders are dumping

I can't see who made the original post as I must have them on Ignore but it sounds like that mrreda idiot. He IS a lying P0S. Last week he made a post that puts his age in his 60's (claimed he had owned a position in company for 40 years) and then a few days later made a post making it sound as though he was half that. He's just trolling people. Sad, really

<< Previous

Bullboard Posts

Next >>

FE Battery Metals begins 2024 winter drill program